🇺🇸 FDA
Patent

US 12064453

Biochemical and biomechanical conditioning for enhancing personalized mesenchymal stem cell therapies

granted A61KA61K2035/124A61K35/28

Quick answer

US patent 12064453 (Biochemical and biomechanical conditioning for enhancing personalized mesenchymal stem cell therapies) held by The Board of Regents of the University of Texas System expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2035/124, A61K35/28, A61K9/0019, A61K9/0024